EUVIMEDEUVIMED entdecken
Crossref

Exonuclease III-Proofread high-fidelity primer exchange reaction enables ultrasensitive analysis of prostate cancer MicroRNA

Jiwei Yao, Guoxian Deng, Xianping Li, Xiaowen Xia, Junan Yan

Biosensors and Bioelectronics · 2027

DOI: 10.1016/j.bios.2026.119288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027. Verfasst von Jiwei Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou City, Jiangsu Province, 225009, China. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms, Biosensing Techniques, Nucleic Acid Amplification Techniques. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Yangzhou University, Chongqing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primer exchange reaction (PER) has emerged as a versatile isothermal amplification technique for biosensing, yet its practical application is severely hampered by non-specific hybridization-induced background signals. Here, we report a high-fidelity PER (Hf-PER) strategy that overcomes this limitation through a rationally designed template architecture integrating exonuclease III (Exo III)-mediated target recycling, blocked primer binding, and self-priming amplification. In this design, Exo III strictly discriminates perfectly matched targets from mismatched sequences, while the absence of free primers and magnetic bead separation effectively suppress spurious amplification. Using miR-21, a prostate cancer-associated biomarker, as a model, the Hf-PER assay achieves a remarkable limit of detection of 0.15 fM with a wide dynamic range spanning five orders of magnitude and single-base discrimination capability. The method demonstrates excellent recovery (95.6%-101.2%) in spiked serum samples, high repeatability (CV 0.99). Moreover, it successfully distinguishes prostate cancer cells from normal cells and accurately identifies miR-21 elevation in clinical serum samples from prostate cancer patients. By simply reprogramming the recognition domain, this platform can be readily adapted for other nucleic acid biomarkers; as a proof of concept, we further applied the Hf-PER strategy to detect miR-155, achieving a limit of detection of 0.21 fM and comparable specificity, demonstrating excellent versatility. The Hf-PER strategy offers a robust, sensitive, specific, and programmable tool for early cancer diagnosis, liquid biopsy, and point-of-care testing, addressing a critical need for reliable isothermal amplification in complex biological matrices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsBiosensing TechniquesNucleic Acid Amplification TechniquesExodeoxyribonucleasesHumansMaleLimit of DetectionBiomarkers, TumorCell Line, Tumor

Stichwörter der Autor:innen

Exonuclease IIIPrimer exchange reactionProstate cancerThTmicroRNA

Substanzen

MicroRNAsexodeoxyribonuclease IIIExodeoxyribonucleasesMIRN21 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou City, Jiangsu Province, 225009, China.
  • Department of Urology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou City, Jiangsu Province, 225009, China. Electronic address: JAY093055@yzu.edu.cn.

Förderung

  • Yangzhou University
  • Chongqing Natural Science Foundation

Zitieren

APA

Yao, J., Deng, G., Li, X., Xia, X., & Yan, J. (2027). Exonuclease III-Proofread high-fidelity primer exchange reaction enables ultrasensitive analysis of prostate cancer MicroRNA. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119288

Vancouver

Yao J, Deng G, Li X, Xia X, Yan J. Exonuclease III-Proofread high-fidelity primer exchange reaction enables ultrasensitive analysis of prostate cancer MicroRNA. Biosensors and Bioelectronics. 2027. doi:10.1016/j.bios.2026.119288

BibTeX
@article{Yao2027,
  author = {Yao, Jiwei and Deng, Guoxian and Li, Xianping and Xia, Xiaowen and Yan, Junan},
  title = {Exonuclease III-Proofread high-fidelity primer exchange reaction enables ultrasensitive analysis of prostate cancer MicroRNA},
  journal = {Biosensors and Bioelectronics},
  year = {2027},
  doi = {10.1016/j.bios.2026.119288}
}
Kostenlos starten →